WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
Ming Yuan Cloud (00909) repurchased 200,000 shares for 655,000 Hong Kong dollars on January 5th.
Boe Technology Group's holding subsidiary Energy Technology has had its listing application on the Belt and Road Exchange accepted.
IGG spent HK$481,700 to repurchase 125,000 shares on January 5th.
Ming Yuan Cloud (00909) repurchased 200,000 shares for 655,000 Hong Kong dollars on January 5th.
Boe Technology Group's holding subsidiary Energy Technology has had its listing application on the Belt and Road Exchange accepted.
IGG spent HK$481,700 to repurchase 125,000 shares on January 5th.
RECOMMEND
Hong Kong Listed Companies’ Return To A Shares Heats Up As New “H To Shenzhen A” Case Emerges
05/01/2026
What Do The Top Ten Biopharma IPOs Of 2025 Tell Us?
05/01/2026
Asia’s Stock Markets Deliver A Strong 2025: Korea Soars 76%, Japan Tops Bubble‑Era Peak, Indonesia Records Best Year In 11 Years
05/01/2026
